Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: Short report

Cytopathology

Volumn 22, Issue 6, 2011, Pages 387-391

  Mollaoglu, N ^a,b   Metzler, P ^a   Zenk, J ^a   Nkenke, E ^a   Neukam, F W ^a   Ries, J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Exfoliative cytology; MAGE A expression; Melanoma associated antigen A; Molecular analysis; Oral squamous cell carcinoma; Recurrence

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MESSENGER RNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOLOGY; EXFOLIATIVE CYTOLOGY; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; ORAL SQUAMOUS CELL CARCINOMA; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CYTOGENETIC ANALYSIS; FEMALE; GP100 MELANOMA ANTIGEN; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 81355147090     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00814.x     Document Type: Article

References (14)

1. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;2:127-35.
2. Pérez-Sayánsm M, Somoza-Martín JM, Barros-Angueira F et al. Exfoliative cytology for diagnosing oral cancer. Biotech Histochem 2010;85:177-87.
3. Navone R. Cytology of the oral cavity: a re-evaluation. Pathologica 2009;101:6-8.
4. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002;68:617-21.
5. Spafford MF, Koch WM, Reed AL et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607.
6. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006;23:5-11.
7. Van Der Bruggen BP, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
8. De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-9.
9. Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 2005;26:817-24.
10. World Health Organization. International Histological Classification of Tumours, 2nd edn. Berlin, Germany: Springer-Verlag; 1988.
11. Silverman S. Oral cancer. Semin Dermatol 1994;13:132-7.
12. De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004;24:4781-90.
13. Ries J, Vairaktaris E, Mollaoglu N et al. Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol Med 2008;37:88-93.
14. Mollaoglu N, Vairaktaris E, Nkenke E, Neukam FW, Ries J. Expression of MAGE-A12 in oral squamous cell carcinoma. Dis Markers 2008;24:27-32.